Women who received a vaccine targeting two types of the human papilloma virus (HPV) that cause 70 percent of cervical cancers had the added benefit of protection against oral HPV infection, which can lead to cancer of the tonsils and throat (oropharyngeal cancer). Researchers at NCI, in collaboration with researchers from Costa Rica, showed that the vaccine reduced oral infections by more than 90 percent. Read more here.
Study mentioned: Herrero R, et al. (2013) Reduced Prevalence of Oral Human Papillomavirus (HPV) 4 Years after Bivalent HPV Vaccination in a Randomized Clinical Trial in Costa Rica. PLoS ONE 8(7): e68329.
No comments:
Post a Comment